Table 2.
Clinical characteristics.
| Clinical characteristics | hyperlipidemia with syndrome of SLQSD | hyperlipidemia with syndrome of non-SLQSD | Healthy volunteers |
|---|---|---|---|
| n | 10 | 19 | 26 |
| Age (X±SD) | 55.6±9.64∗ | 54.26±8.05∗∗ | 46.73±7.74 |
| Gender [Female (%)] | 60.0 | 63.2 | 53.8 |
| TC | 4.90±0.69∗∗## | 5.88±0.72∗∗ | 4.37±0.60 |
| TG | 2.24±0.84∗∗ | 2.00±1.27∗∗ | 1.02±0.26 |
| HDL-C | 1.17±0.31 | 1.40±0.33 | 1.37±0.27 |
| LDL-C | 2.80±0.56## | 3.55±0.75∗∗ | 2.50±0.48 |
| VDL-C | 0.96±0.25∗∗ | 0.93±0.50∗∗ | 0.49±0.14 |
| ApoA1 | 1.36±0.30 | 1.44±0.19 | 1.40±0.18 |
| ApoB | 1.02±0. 25 | 1.15±0. 31∗∗ | 0.83±0. 16 |
Gender was expressed as percentage and the other data were expressed as mean ± SD. ∗p<0.05 and ∗∗p< 0.01 compared with healthy volunteer group. Hyperlipidemia with syndrome of SLQSD compared with hyperlipidemia with syndrome of non-SLQSD, #p<0.05, and ##p < 0.01.